
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5
Huiping Shuai, Jasper Fuk‐Woo Chan, Bingjie Hu, et al.
EBioMedicine (2023) Vol. 95, pp. 104753-104753
Open Access | Times Cited: 35
Huiping Shuai, Jasper Fuk‐Woo Chan, Bingjie Hu, et al.
EBioMedicine (2023) Vol. 95, pp. 104753-104753
Open Access | Times Cited: 35
Showing 1-25 of 35 citing articles:
COVID-19 drug discovery and treatment options
Jasper Fuk‐Woo Chan, Shuofeng Yuan, Hin Chu, et al.
Nature Reviews Microbiology (2024) Vol. 22, Iss. 7, pp. 391-407
Closed Access | Times Cited: 17
Jasper Fuk‐Woo Chan, Shuofeng Yuan, Hin Chu, et al.
Nature Reviews Microbiology (2024) Vol. 22, Iss. 7, pp. 391-407
Closed Access | Times Cited: 17
SARS-CoV-2 omicron BA.5 and XBB variants have increased neurotropic potential over BA.1 in K18-hACE2 mice and human brain organoids
Romal Stewart, Kexin Yan, Sevannah A. Ellis, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 22
Romal Stewart, Kexin Yan, Sevannah A. Ellis, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 22
Mutational dynamics of SARS-CoV-2: Impact on future COVID-19 vaccine strategies
Niloofar Faraji, Tahereh Zeinali, Farahnaz Joukar, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30208-e30208
Open Access | Times Cited: 11
Niloofar Faraji, Tahereh Zeinali, Farahnaz Joukar, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30208-e30208
Open Access | Times Cited: 11
Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines
Congrui Zhu, Shengmei Pang, Jiaqi Liu, et al.
Drugs (2024) Vol. 84, Iss. 4, pp. 403-423
Closed Access | Times Cited: 9
Congrui Zhu, Shengmei Pang, Jiaqi Liu, et al.
Drugs (2024) Vol. 84, Iss. 4, pp. 403-423
Closed Access | Times Cited: 9
Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3
Yuanchen Liu, Xiaoyu Zhao, Jialu Shi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Yuanchen Liu, Xiaoyu Zhao, Jialu Shi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Potent and broadly neutralizing antibodies against sarbecoviruses elicited by single ancestral SARS-CoV-2 infection
Lei Yu, Yajie Wang, Yuanchen Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Lei Yu, Yajie Wang, Yuanchen Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Animal Models for Human-Pathogenic Coronavirus and Animal Coronavirus Research
Fenglian Xiao, Jincheng Hu, Minsheng Xu, et al.
Viruses (2025) Vol. 17, Iss. 1, pp. 100-100
Open Access
Fenglian Xiao, Jincheng Hu, Minsheng Xu, et al.
Viruses (2025) Vol. 17, Iss. 1, pp. 100-100
Open Access
Accelerated Adaptation of SARS-CoV-2 Variants in Mice Lacking IFITM3 Preserves Distinct Tropism and Pathogenesis
Parker Denz, Jonathan L. Papa, Matthew I. McFadden, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Parker Denz, Jonathan L. Papa, Matthew I. McFadden, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Potent and broadly neutralizing antibodies against sarbecoviruses elicited by single ancestral SARS-CoV-2 infection
Yu Lei, Yajie Wang, Yuanchen Liu, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Yu Lei, Yajie Wang, Yuanchen Liu, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Effect of metformin in hypothalamic astrocytes from an immunocompromised mice model
Larissa Daniele Bobermin, Daniele Schauren da Costa, Aline Daniel Moreira de Moraes, et al.
Biochimie (2024) Vol. 223, pp. 196-205
Closed Access | Times Cited: 4
Larissa Daniele Bobermin, Daniele Schauren da Costa, Aline Daniel Moreira de Moraes, et al.
Biochimie (2024) Vol. 223, pp. 196-205
Closed Access | Times Cited: 4
Interferon signaling in the nasal epithelium distinguishes among lethal and common cold coronaviruses and mediates viral clearance
Clayton J. Otter, David M. Renner, Alejandra Fausto, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 21
Open Access | Times Cited: 4
Clayton J. Otter, David M. Renner, Alejandra Fausto, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 21
Open Access | Times Cited: 4
Divergent trajectory of replication and intrinsic pathogenicity of SARS-CoV-2 Omicron post-BA.2/5 subvariants in the upper and lower respiratory tract
Bingjie Hu, Jasper Fuk‐Woo Chan, Yuanchen Liu, et al.
EBioMedicine (2023) Vol. 99, pp. 104916-104916
Open Access | Times Cited: 10
Bingjie Hu, Jasper Fuk‐Woo Chan, Yuanchen Liu, et al.
EBioMedicine (2023) Vol. 99, pp. 104916-104916
Open Access | Times Cited: 10
Differential pathogenic and molecular features in neurological infection of SARS‐CoV‐2 Omicron BA.5.2 and BA.2.75 and Delta
Erlin Wang, Qiaojiang Yang, Xiang‐Xiong Xu, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Closed Access | Times Cited: 3
Erlin Wang, Qiaojiang Yang, Xiang‐Xiong Xu, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Closed Access | Times Cited: 3
Tracking inflammation resolution signatures in lungs after SARS-CoV-2 omicron BA.1 infection of K18-hACE2 mice
Agnes Carolin, Kexin Yan, Cameron Bishop, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Agnes Carolin, Kexin Yan, Cameron Bishop, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Divergent pathogenetic outcomes in BALB/c mice following Omicron subvariant infection
John M. Powers, Sarah R. Leist, Michael L. Mallory, et al.
Virus Research (2024) Vol. 341, pp. 199319-199319
Open Access | Times Cited: 2
John M. Powers, Sarah R. Leist, Michael L. Mallory, et al.
Virus Research (2024) Vol. 341, pp. 199319-199319
Open Access | Times Cited: 2
Type‐II IFN inhibits SARS‐CoV‐2 replication in human lung epithelial cells and ex vivo human lung tissues through indoleamine 2,3‐dioxygenase‐mediated pathways
Dong Yang, Jasper Fuk‐Woo Chan, Chaemin Yoon, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 2
Open Access | Times Cited: 2
Dong Yang, Jasper Fuk‐Woo Chan, Chaemin Yoon, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 2
Open Access | Times Cited: 2
SARS-CoV-2 Omicron subvariants progressively adapt to human cells with altered host cell entry
Yasuteru Sakurai, Sayaka Okada, Takehiro Ozeki, et al.
mSphere (2024) Vol. 9, Iss. 9
Open Access | Times Cited: 2
Yasuteru Sakurai, Sayaka Okada, Takehiro Ozeki, et al.
mSphere (2024) Vol. 9, Iss. 9
Open Access | Times Cited: 2
Ultrapotent class I neutralizing antibodies post Omicron breakthrough infection overcome broad SARS-CoV-2 escape variants
Mengxiao Luo, Runhong Zhou, Bingjie Tang, et al.
EBioMedicine (2024) Vol. 108, pp. 105354-105354
Open Access | Times Cited: 2
Mengxiao Luo, Runhong Zhou, Bingjie Tang, et al.
EBioMedicine (2024) Vol. 108, pp. 105354-105354
Open Access | Times Cited: 2
Infection kinetics, syncytia formation, and inflammatory biomarkers as predictive indicators for the pathogenicity of SARS-CoV-2 Variants of Concern in Calu-3 cells
Priyo Budi Purwono, Vimvara Vacharathit, Suwimon Manopwisedjaroen, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0301330-e0301330
Open Access | Times Cited: 2
Priyo Budi Purwono, Vimvara Vacharathit, Suwimon Manopwisedjaroen, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0301330-e0301330
Open Access | Times Cited: 2
Causes and Consequences of Coronavirus Spike Protein Variability
Fabian Zech, Christoph Jung, Timo Jacob, et al.
(2024)
Open Access | Times Cited: 1
Fabian Zech, Christoph Jung, Timo Jacob, et al.
(2024)
Open Access | Times Cited: 1
Mathematical model explains differences in Omicron and Delta SARS-CoV-2 dynamics in Caco-2 and Calu-3 cells
В. М. Староверов, Alexei Galatenko, E. N. Knyazev, et al.
PeerJ (2024) Vol. 12, pp. e16964-e16964
Open Access | Times Cited: 1
В. М. Староверов, Alexei Galatenko, E. N. Knyazev, et al.
PeerJ (2024) Vol. 12, pp. e16964-e16964
Open Access | Times Cited: 1
Establishment and characterization of an hACE2/hTMPRSS2 knock-in mouse model to study SARS-CoV-2
Hongwei Liu, Terza Brostoff, Ana Ramírez, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Hongwei Liu, Terza Brostoff, Ana Ramírez, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Virological characteristics of SARS-CoV-2 Omicron BA.5.2.48
Wenqi Wang, Qiushi Jin, Ruixue Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Wenqi Wang, Qiushi Jin, Ruixue Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Causes and Consequences of Coronavirus Spike Protein Variability
Fabian Zech, Christoph Jung, Timo Jacob, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 177-177
Open Access
Fabian Zech, Christoph Jung, Timo Jacob, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 177-177
Open Access
Virological characteristics of SARS-CoV-2 Omicron BA.5.2.48
Wenqi Wang, Qiushi Jin, Ruixue Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Wenqi Wang, Qiushi Jin, Ruixue Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access